Business Services · California, United States · 13,638 Employees
Genentech uses at least 5 email formats with last.first (ex. Smith.John@gene.com) being used 71% of the time
Get Verified Emails
Genentech Email Formats | Percentage | |
---|---|---|
last.first | Smith.John@gene.com | 71% |
first.last | John.Smith@gene.com | |
first + last | JohnSmith@gene.com | |
first_last | John_Smith@gene.com | |
first | John@gene.com |
Funding Date | Round | Amount | Investors | |
---|---|---|---|---|
Jun 30, 1976 | Unspecified | $100M | Kleiner Perkins Caufield & Byers |
$100M
Total Funding Amount
$100M
Most Recent Funding Amount
1
Number of Funding Rounds
Quarter | Revenue |
---|---|
'21 - Q1 | 6051874000 |
'21 - Q2 | 6051874000 |
Oct 31, 2017
PVT Probenverteiltechnik
Jun 23, 2017
Tusk Therapeutics
Dec 06, 2016
Jecure Therapeutics
Sep 16, 2013
Seragon Pharmaceuticals
Jul 24, 2013
Genable Technologies
Jan 17, 2012
Ariosa Diagnostics
See More Acquisitions & Subsidiaries
Genentech’s headquarters are in 1 Dna Way Mailstop 258A, South San Francisco, California, 94080, United States
Genentech’s phone number is (650) 225-2500
Genentech’s official website is www.gene.com
Genentech’s revenue is $6 Billion
Genentech’s SIC: 28,283
Genentech’s NAICS: 541711,3254
Genentech has 13,638 employees
Genentech is in the industry of: Business Services, Research & Development, Manufacturing
Genentech's main competitors are: Biogen, Seattle Genetics, Amgen, CSL
Genentech has acquired the companies: PVT Probenverteiltechnik, Tusk Therapeutics, Jecure Therapeutics, Seragon Pharmaceuticals
The technologies that are used by Genentech are: Tenable, LabVIEW, Dataiku, Westlaw
Genentech's CEO is Alexander Hardy
Genentech's CFO is Ed Harrington